The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A post hoc analysis.
双重葡萄糖依赖性促胰岛素多肽和胰高血糖素样肽-1受体激动剂替拉帕肽可改善2型糖尿病患者的心血管风险生物标志物：一项事后分析
期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14553
Wilson Jonathan M, Lin Yanzhu, Luo M Jane, Considine Gary, Cox Amy L, Bowsman Lenden M, Robins Deborah A, Haupt Axel, Duffin Kevin L, Ruotolo Giacomo
